Resultados de la búsqueda 491-500 of 71857 for Treatment
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...
... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). Cohort 2 includes (1) muCALR+ primary MF, and (2) muCALR+ secondary MF ...
... treatment. A Registry Called Every Child for Collecting Data and Biology Specimens on Younger Patients with Cancer. Rochester, Minn. The purpose of this ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...
... treatment of advanced colorectal carcinoma. The primary study ... treatment, in order to classify patients into post-consolidation treatment groups.
Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...
Once this is complete treatment will be directed based on the genomic signature of patients individual tumor. Tumor Molecular Analysis. Rochester, Minn., ...
... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?